CN101586162A - 一种提取靶核酸并进行pcr扩增检测的方法 - Google Patents
一种提取靶核酸并进行pcr扩增检测的方法 Download PDFInfo
- Publication number
- CN101586162A CN101586162A CNA2009100436522A CN200910043652A CN101586162A CN 101586162 A CN101586162 A CN 101586162A CN A2009100436522 A CNA2009100436522 A CN A2009100436522A CN 200910043652 A CN200910043652 A CN 200910043652A CN 101586162 A CN101586162 A CN 101586162A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- target nucleic
- pcr
- performing pcr
- augmentation detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 62
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 44
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 44
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 44
- 230000003416 augmentation Effects 0.000 title claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract description 4
- 239000000523 sample Substances 0.000 claims description 35
- 238000000605 extraction Methods 0.000 claims description 20
- 238000012408 PCR amplification Methods 0.000 claims description 16
- 230000003321 amplification Effects 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 238000003753 real-time PCR Methods 0.000 claims description 15
- 239000006166 lysate Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 8
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 6
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 6
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 6
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 5
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 4
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 3
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 3
- 206010036790 Productive cough Diseases 0.000 claims description 2
- 238000013461 design Methods 0.000 claims description 2
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- 210000003802 sputum Anatomy 0.000 claims description 2
- 208000024794 sputum Diseases 0.000 claims description 2
- 239000000284 extract Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 238000005336 cracking Methods 0.000 abstract description 3
- 244000000010 microbial pathogen Species 0.000 abstract description 3
- 238000009582 blood typing Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 41
- 241000700721 Hepatitis B virus Species 0.000 description 25
- 239000000243 solution Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 11
- 238000009835 boiling Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 239000002245 particle Substances 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 239000004141 Sodium laurylsulphate Substances 0.000 description 7
- 230000005291 magnetic effect Effects 0.000 description 7
- 230000005298 paramagnetic effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012925 reference material Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 6
- 230000002934 lysing effect Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- -1 methane amide Chemical class 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 238000001921 nucleic acid quantification Methods 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
成分 | 单人份用量 |
(上游)引物HBV-F1(50pmol/μl) | 0.2μl |
(下游)引物HBV-F1(50pmol/μl) | 0.2μl |
HBV探针HBV-P1(50pmol/μl) | 0.1μl |
ROX溶液(10μmol/L) | 1μl |
dNTPs | 0.4μl |
10×PCR buffer | 5μl |
灭菌纯化水 | 38.1μl |
总量 | 45μl |
线性灵敏度参考品 | 质量标准(IU/ml) | 理论浓度对数值 | 检测值 | 检测浓度对数值 |
L0 | 7.762×107~6.165×108 | 8.342 | 2.55×108 | 8.407 |
L1 | 1.479×107~1.175×108 | 7.619 | 3.54×107 | 7.549 |
L2 | 1.585×106~1.259×107 | 6.649 | 4.43×106 | 6.646 |
L3 | 1.659×105~1.318×106 | 5.672 | 3.41×105 | 5.382 |
L4 | 1.820×104~1.479×105 | 4.715 | 1.38×104 | 4.140 |
L5 | 1.514×103~1.230×104 | 3.636 | 1.71×103 | 3.233 |
L6 | 3.890×101~3.090×102 | 2.043 | 5.64×101 | 1.751 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100436522A CN101586162B (zh) | 2009-06-10 | 2009-06-10 | 一种提取靶核酸并进行pcr扩增检测的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100436522A CN101586162B (zh) | 2009-06-10 | 2009-06-10 | 一种提取靶核酸并进行pcr扩增检测的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101586162A true CN101586162A (zh) | 2009-11-25 |
CN101586162B CN101586162B (zh) | 2011-02-09 |
Family
ID=41370588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100436522A Active CN101586162B (zh) | 2009-06-10 | 2009-06-10 | 一种提取靶核酸并进行pcr扩增检测的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101586162B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101701267A (zh) * | 2009-11-26 | 2010-05-05 | 戴立忠 | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 |
CN102807975A (zh) * | 2011-05-30 | 2012-12-05 | 熊慧 | 一种从生物样本中快速提取核酸的方法 |
CN103184214A (zh) * | 2011-12-27 | 2013-07-03 | 上海复星医学科技发展有限公司 | 一种乙型肝炎病毒核酸快速提取试剂 |
CN104450674A (zh) * | 2013-09-24 | 2015-03-25 | 上海艾迪康医学检验所有限公司 | 核酸提取保存液 |
CN105004596A (zh) * | 2010-02-23 | 2015-10-28 | 卢米尼克斯公司 | 用于整合的样品制备、反应和检测的器械和方法 |
CN108531563A (zh) * | 2018-02-05 | 2018-09-14 | 深圳市尚维高科有限公司 | 多孔微球的用途及裂解液以及裂解液的使用方法 |
CN108977436A (zh) * | 2018-08-10 | 2018-12-11 | 邵忠民 | 生物核酸dna快速释放提取试剂以及制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100360684C (zh) * | 2005-02-01 | 2008-01-09 | 合肥中科大生物技术有限公司 | 甲胎蛋白(AFP)mRNA荧光定量RT-PCR检测试剂盒 |
CN100352943C (zh) * | 2006-04-14 | 2007-12-05 | 武汉大学 | 快速检测沙眼衣原体的荧光定量pcr试剂盒 |
-
2009
- 2009-06-10 CN CN2009100436522A patent/CN101586162B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101701267A (zh) * | 2009-11-26 | 2010-05-05 | 戴立忠 | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 |
CN101701267B (zh) * | 2009-11-26 | 2012-09-19 | 戴立忠 | 乙型肝炎病毒荧光定量pcr检测试剂盒及其应用 |
CN105004596A (zh) * | 2010-02-23 | 2015-10-28 | 卢米尼克斯公司 | 用于整合的样品制备、反应和检测的器械和方法 |
CN102807975A (zh) * | 2011-05-30 | 2012-12-05 | 熊慧 | 一种从生物样本中快速提取核酸的方法 |
CN102807975B (zh) * | 2011-05-30 | 2014-10-29 | 熊慧 | 一种从生物样本中快速提取核酸的方法 |
CN103184214A (zh) * | 2011-12-27 | 2013-07-03 | 上海复星医学科技发展有限公司 | 一种乙型肝炎病毒核酸快速提取试剂 |
CN103184214B (zh) * | 2011-12-27 | 2016-02-10 | 上海星耀医学科技发展有限公司 | 一种乙型肝炎病毒核酸快速提取试剂 |
CN104450674A (zh) * | 2013-09-24 | 2015-03-25 | 上海艾迪康医学检验所有限公司 | 核酸提取保存液 |
CN108531563A (zh) * | 2018-02-05 | 2018-09-14 | 深圳市尚维高科有限公司 | 多孔微球的用途及裂解液以及裂解液的使用方法 |
CN108977436A (zh) * | 2018-08-10 | 2018-12-11 | 邵忠民 | 生物核酸dna快速释放提取试剂以及制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101586162B (zh) | 2011-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3636769B1 (en) | Sample nucleic acid measurement test kit, reagent, and application thereof | |
CN101586162B (zh) | 一种提取靶核酸并进行pcr扩增检测的方法 | |
CN107475252B (zh) | 一种核酸释放剂及快速释放核酸的方法及其应用 | |
CN107299097A (zh) | 一种微量核酸释放剂、制备方法及其应用 | |
CN111424119B (zh) | SARS-CoV-2病毒的高通量检测引物及试剂盒 | |
CN111304361A (zh) | 一种检测非洲猪瘟病毒的试剂盒及检测非洲猪瘟病毒的方法 | |
CN101144771A (zh) | 检测人类免疫缺陷病毒的方法及试剂盒 | |
CN102827947B (zh) | 快速定量检测肝炎病毒核酸的试剂盒及检测方法 | |
CN103184214A (zh) | 一种乙型肝炎病毒核酸快速提取试剂 | |
CN106497916A (zh) | 一种用于高通量测序检测的nk细胞多基因变异文库的构建方法及其应用 | |
CN113718064A (zh) | 一种鉴别pcv2和pcv3的探针引物组合、试剂盒及应用 | |
CN106987588B (zh) | 一种病毒/细菌的裂解液及荧光定量pcr检测方法 | |
CN103540687A (zh) | 对虾白斑综合症病毒(wssv)的lamp检测引物组及试剂盒 | |
CN112195278A (zh) | 一种六项呼吸道病毒核酸检测试剂盒及使用方法 | |
CN115323075B (zh) | 一种检测鸡传染性支气管炎病毒及基因分型的rt-raa引物探针组、试剂盒及其应用 | |
CN113930418A (zh) | 核酸释放剂及其核酸释放方法 | |
CN114634996A (zh) | 用于检测牛呼吸道疾病的引物探针组合、试剂盒及其应用 | |
CN107365766A (zh) | 机械破碎法提取霉菌孢子rna的方法 | |
CN110684862B (zh) | 用于定量检测乙型肝炎病毒的微滴数字pcr试剂盒及检测方法 | |
CN113151579A (zh) | 鸭甲型肝炎病毒1型和鸭星状病毒3型双重实时荧光定量pcr检测用引物及检测方法 | |
CN111154836A (zh) | 靶向核酸捕获和检测方法 | |
CN104762414A (zh) | 荧光可视化快速检测流行性乙型脑炎病毒的rt-lamp试剂盒 | |
AU2021103963A4 (en) | Paper-based chromatographic viral nucleic acid extraction kit | |
CN117568493B (zh) | 一种用于鉴定昆虫细胞系的试剂及试剂盒 | |
CN117403009B (zh) | 一种用于联合检测四种牛源性rna病毒的试剂及试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091125 Assignee: Sansure Biotech Inc. Assignor: Dai Lizhong Contract record no.: 2013430000093 Denomination of invention: Method of extracting target nucleic acid and performing PCR augmentation Granted publication date: 20110209 License type: Exclusive License Record date: 20130626 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: HUNAN SHENGWEI GENE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: DAI LIZHONG Effective date: 20141203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 410205 CHANGSHA, HUNAN PROVINCE TO: 410012 CHANGSHA, HUNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141203 Address after: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Patentee after: HUNAN SHENGWEI GENE TECHNOLOGY CO., LTD. Address before: 410205 No. 198 west slope, Yuelu District, Hunan, Changsha, Tongzi Patentee before: Dai Lizhong |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160706 Address after: 410012 No. 680, Lu Song Road, Changsha hi tech Industrial Development Zone, Hunan Patentee after: Sansure Biotech Inc. Address before: 410012, No. 680, Lu Song Road, Changsha hi tech Development Zone, Hunan Patentee before: HUNAN SHENGWEI GENE TECHNOLOGY CO., LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method of extracting target nucleic acid and performing PCR augmentation Effective date of registration: 20170711 Granted publication date: 20110209 Pledgee: Ningbo free trade zone Terry with equity investment partnership (limited partnership)|Suzhou equity equity investment center (limited partnership)|Ningbo Meishan Bonded Port District, Jun and equity investment partnership (limited partnership)|Chen Bang Pledgor: Hunan Gene Technology Co.|Hunan San Xiang Biological Technology Co. Ltd. Registration number: 2017430000042 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 410205 Changsha province high and New Technology Industrial Development Zone, Lu Pine Road, No. 680, Hunan Patentee after: Shengxiang Biotechnology Co., Ltd Address before: 410012 No. 680, Lu Song Road, Changsha hi tech Industrial Development Zone, Hunan Patentee before: Sansure Biotech Inc. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200217 Granted publication date: 20110209 Pledgee: Suzhou Lirui equity investment center (limited partnership)|Triton equity investment partnership (limited partnership)|JUNHE Tongrui equity investment partnership (limited partnership)|Chenbang Pledgor: SANSURE BIOTECH Inc. Registration number: 2017430000042 |